Back to Search
Start Over
Treating moderate-to-severe atopic dermatitis with benralizumab: results from the HILLIER study, a plain language summary.
- Source :
-
Immunotherapy [Immunotherapy] 2024; Vol. 16 (10), pp. 641-648. Date of Electronic Publication: 2024 May 02. - Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 1750-7448
- Volume :
- 16
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Immunotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 38695680
- Full Text :
- https://doi.org/10.2217/imt-2023-0319